🔗 Share this article

Former Prime Minister Rishi Sunak has reinforced his call for a targeted screening programme for prostate cancer.

In a recent conversation, he declared being "persuaded of the immediate need" of implementing such a system that would be cost-effective, achievable and "protect countless lives".

His comments come as the UK National Screening Committee reconsiders its decision from five years ago declining to suggest routine screening.

Media reports propose the committee may continue with its current stance.

Olympic Champion Adds Support to Movement

Gold medal cyclist Sir Hoy, who has late-stage prostate gland cancer, advocates for younger men to be tested.

He proposes lowering the eligibility age for accessing a prostate-specific antigen blood test.

At present, it is not standard practice to healthy individuals who are below fifty.

The PSA examination remains disputed however. Measurements can elevate for causes other than cancer, such as infections, resulting in false positives.

Critics argue this can result in unwarranted procedures and adverse effects.

Focused Screening Proposal

The proposed examination system would concentrate on males between 45 and 69 with a hereditary background of prostate gland cancer and black men, who encounter twice the likelihood.

This demographic includes around 1.3 million individuals individuals in the United Kingdom.

Research projections suggest the programme would necessitate £25 million a year - or about £18 per participant - similar to intestinal and breast screening.

The projection envisions 20% of eligible men would be invited each year, with a 72% uptake rate.

Medical testing (scans and tissue samples) would need to rise by almost a quarter, with only a modest growth in healthcare personnel, as per the report.

Medical Community Reaction

Several healthcare professionals remain uncertain about the value of examination.

They assert there is still a chance that patients will be treated for the disease when it is not strictly necessary and will then have to live with side effects such as bladder issues and impotence.

One prominent urology expert commented that "The problem is we can often detect disease that may not require to be addressed and we end up causing harm...and my apprehension at the moment is that risk to reward ratio needs adjustment."

Individual Perspectives

Individual experiences are also affecting the debate.

One instance involves a man in his mid-sixties who, after asking for a blood examination, was diagnosed with the condition at the age of fifty-nine and was advised it had spread to his pelvis.

He has since received chemo treatment, radiotherapy and hormonal therapy but cannot be cured.

The individual advocates examination for those who are at higher risk.

"This is crucial to me because of my boys – they are approaching middle age – I want them checked as quickly. If I had been screened at 50 I am confident I would not be in the circumstances I am today," he stated.

Next Steps

The Medical Screening Authority will have to evaluate the evidence and arguments.

While the latest analysis suggests the consequences for personnel and availability of a examination system would be achievable, opposing voices have maintained that it would redirect diagnostic capabilities from individuals being cared for for different health issues.

The continuing debate emphasizes the complicated balance between prompt identification and possible unnecessary management in prostate gland cancer care.